Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Seagen Inc (SGEN)  
$228.74 0.00 (0.00%) as of 4:30 Wed 12/13


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 180,310,000
Market Cap: 41.24(B)
Last Volume: 799,597 Avg Vol: 865,224
52 Week Range: $191.51 - $228.9
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 39,326 484,602
Total Sell Value $0 $0 $8,245,949 $88,100,996
Total People Sold 0 0 7 8
Total Sell Transactions 0 0 18 70
End Date 2024-03-24 2023-12-22 2023-06-23 2022-06-23

   
Records found: 1805
  Page 33 of 73  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baker Brothers Life Sciences Lp Director   –       •       •   2016-03-04 4 B $31.68 $9,322,814 I/I 288,058 36,627,462 2.25     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2016-03-02 4 B $32.24 $13,068,812 I/I 400,000 36,367,808 2.25     -
   Cline Darren S Executive Vice President   •       –      –    2016-03-01 4 A $0.00 $0 D/D 8,400 46,113     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2016-03-01 4 B $31.24 $756,112 I/I 24,200 36,007,250 2.25     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2016-02-29 4 B $30.34 $7,650,310 I/I 251,722 35,985,436 2.25     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2016-02-26 4 B $30.13 $1,334,945 I/I 44,300 35,758,535 2.25     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2016-02-25 4 B $29.86 $4,261,553 I/I 142,702 35,718,720 2.25     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2016-02-24 4 B $28.47 $3,696,568 I/I 127,506 35,590,465 2.25     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2016-02-22 4 B $30.21 $7,354,639 I/I 243,411 35,475,868 2.25     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2016-02-19 4 B $29.20 $14,790,559 I/I 506,526 35,257,100 2.25     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2016-02-18 4 B $29.94 $7,530,349 I/I 251,534 34,800,251 2.25     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2016-02-17 4 B $31.25 $25,161,936 I/I 805,267 34,573,386 2.25     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2016-02-16 4 B $29.19 $8,049,663 I/I 270,163 33,847,095 2.25     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2016-02-12 4 B $27.28 $5,410,745 I/I 193,717 3,933,240 2.25     -
   Orwin John A Director   –       •      –    2016-02-12 4 B $28.33 $56,660 D/D 2,000 10,700 2.39     -
   Himes Vaughn B EVP, Proc Svcs & Tech Ops   •       –      –    2015-12-15 4 S $39.94 $1,617,493 D/D (40,500) 76,212     -
   Himes Vaughn B EVP, Proc Svcs & Tech Ops   •       –      –    2015-12-15 4 OE $9.23 $373,815 D/D 40,500 116,712     -
   Siegall Clay B President and CEO   •       •      –    2015-12-03 4 AS $39.99 $148,763 D/D (3,720) 556,115     -
   Siegall Clay B President and CEO   •       •      –    2015-12-03 4 OE $5.63 $20,944 D/D 3,720 559,835     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2015-11-20 4 B $43.87 $7,988,259 I/I 181,647 33,428,852 2.25     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2015-11-19 4 B $43.93 $5,845,378 I/I 133,073 33,247,205 2.25     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2015-11-18 4 B $43.00 $638,321 I/I 14,638 33,114,132 2.25     -
   Siegall Clay B President and CEO   •       •      –    2015-11-17 4 S $45.40 $3,970,951 D/D (87,473) 556,115     -
   Cline Darren S SVP, Commercial   •       –      –    2015-11-11 4 S $45.68 $263,548 D/D (5,769) 37,713     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2015-11-10 4 B $44.00 $413,600 I/I 9,400 33,099,494 2.25     -
  1805 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 33 of 73
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us